“Risk of Arterial and Venous Thromboembolic Events with Bevacizumab, an Antibody against Vascular Endothelial Growth Factor A (VEGF-A): A Systematic Review and Meta-Analysis” (2020) Global Journal of Medical Research, 20(B1), pp. 71–85. Available at: https://medicalresearchjournal.org/index.php/GJMR/article/view/1952 (Accessed: 13 August 2026).